Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine
Background. Hemophilia A is an X-linked recessive bleeding disorder caused by mutations in FVIII gene with an incidence of 1 in 5,000 to 10,000 live born males. The Inv22 mutation is a major cause of the disease worldwide, accounting for up to 40%–50% of severe FVIII mutations. The aim of the presen...
Main Authors: | Caesar Mahmoud Abu Arra, Fekri Samarah, Nael Sudqi Abu Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Scientifica |
Online Access: | http://dx.doi.org/10.1155/2020/3428648 |
Similar Items
-
Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion
by: Jeong Pil Han, et al.
Published: (2021-07-01) -
Identification of intron 1 and intron 22 inversions of factor VIII gene in Serbian patients with hemophilia A
by: Ilić Nina, et al.
Published: (2013-01-01) -
Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A
by: Aveen M. Raouf Abdulqader MD, PhD, et al.
Published: (2020-01-01) -
Factor VIII-Intron 1 Inversion of Hemophilia A Patients In West Anatolia
by: Pehlivan M, et al.
Published: (2007-04-01) -
Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
by: Laila M. Sherief, et al.
Published: (2020-09-01)